Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-22

FDA Approved: FULVESTRANT — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' original application for a generic Fulvestrant product. Fulvestrant is used to treat hormone receptor-positive metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)